examin
associ
certain
clinic
factor
aflatoxin
b
albumin
adduct
afalb
level
hivposit
peopl
plasma
sampl
collect
hivposit
hivneg
peopl
test
afalb
level
viral
load
tcell
count
liver
function
profil
malaria
parasitaemia
hepat
b
c
viru
infect
hivposit
particip
divid
high
low
group
base
median
afalb
pmol
mg
albumin
multivari
logist
linear
regress
method
use
assess
relationship
clinic
condit
afalb
level
multivari
logist
regress
show
statist
signific
increas
odd
higher
hiv
viral
load
higher
direct
bilirubin
level
among
hivposit
particip
high
afalb
group
also
higher
level
total
bilirubin
lower
level
albumin
associ
high
afalb
thu
aflatoxin
exposur
may
contribut
high
viral
load
abnorm
liver
function
hivposit
peopl
promot
diseas
progress
subsaharan
africa
region
heavili
affect
hivaid
epidem
unaid
estim
million
peopl
live
hivaid
region
twothird
global
total
hivaid
death
sinc
begin
hivaid
pandem
occur
subsaharan
africa
although
access
antiretrovir
therapi
art
decreas
death
toll
aid
fewer
half
african
need
treatment
receiv
whounaidsunicef
therefor
impact
aid
remain
sever
region
sever
year
come
aflatoxin
group
extrem
toxic
fungal
metabolit
gourama
bullerman
found
stapl
food
crop
groundnut
maiz
rice
grain
freita
brigido
carvaj
arroyo
begum
samajpati
park
et
al
mani
develop
countri
latitud
william
et
al
potent
cytotox
carcinogen
immunomodulatori
immunosuppress
agent
joint
faowho
expert
committe
food
addit
pier
pestka
bondi
jecfa
omer
et
al
shown
high
aflatoxin
b
albumin
adduct
afalb
level
appear
result
immun
impair
hivneg
person
jiang
et
al
accentu
hivassoci
chang
tcell
phenotyp
bcell
hivposit
peopl
may
facilit
hivassoci
immun
hyperactiv
lead
sever
diseas
diseas
progress
jiang
et
al
approxim
billion
peopl
estim
chronic
expos
aflatoxin
worldwid
therefor
toll
human
health
consid
enorm
william
et
al
aflatoxin
b
afb
usual
predomin
toxic
aflatoxin
b
g
oxid
afb
cytochrom
enzym
system
guengerich
shimada
highli
reactiv
epoxid
bind
dna
rna
protein
result
cancer
toxic
eaton
gallagh
sever
effect
aflatoxin
human
bodi
seen
liver
organ
gener
respons
detoxifi
chemic
agent
poison
acut
aflatoxicosi
bind
afb
variou
cellular
macromolecul
lead
hepatocellular
injuri
death
anim
experi
human
acut
expos
aflatoxin
liver
specimen
show
signific
necrosi
parenchym
cell
extens
prolifer
bile
duct
cullen
newborn
previous
found
abnorm
liver
function
lowhigh
total
protein
low
albumin
high
alanin
aminotransferas
ast
level
approxim
hivneg
ghanaian
expos
aflatoxin
diet
jolli
et
al
chronic
aflatoxin
exposur
shown
interfer
metabol
protein
roebuck
maxuitenko
food
convers
shane
growth
edd
marin
et
al
turner
et
al
number
micronutri
critic
health
immun
function
abdelhamid
et
al
harvey
et
al
william
et
al
preexist
liver
diseas
hepat
b
viru
hbv
hepat
c
viru
hcv
may
compromis
abil
hepatocyt
inactiv
carcinogen
aflatoxin
zhou
et
al
aflatoxin
hbv
shown
work
synergist
increas
risk
liver
cancer
peer
et
al
wild
et
al
previous
found
hivneg
ghanaian
posit
hepat
infect
hbv
hcv
thu
certain
clinic
factor
may
predict
high
aflatoxin
level
human
especi
hivposit
individu
alreadi
suffer
sever
compromis
health
effect
hiv
hivposit
peopl
shown
high
rate
liver
injuri
indic
elev
liver
enzym
andor
bilirubin
level
may
due
medic
hbv
hcv
coinfect
andor
alcohol
use
bonacini
druginduc
liver
injuri
may
due
highli
activ
antiretrovir
therapi
haart
drug
ritonavir
antituberculosi
medic
sulkowski
et
al
soriano
et
al
malaria
infect
number
one
caus
morbid
account
outpati
visit
ghana
asant
asensookyer
thu
malaria
hiv
two
major
diseas
public
health
import
subsaharan
africa
immun
suppress
occur
hiv
infect
shown
correl
increas
incid
clinic
malaria
martinblond
et
al
although
role
subclin
malaria
uncertain
transient
elev
hiv
viral
load
febril
malaria
episod
occur
thu
conduct
studi
measur
compar
afalb
level
plasma
group
hivneg
posit
ghanaian
examin
differ
clinic
factor
viral
load
count
liver
function
paramet
hbv
hcv
malaria
infect
among
hivposit
particip
lower
higher
afalb
level
crosssect
studi
afalb
level
hivneg
posit
peopl
conduct
kumasi
heavi
maiz
groundnut
produc
consum
area
ashanti
region
ghana
approv
studi
obtain
institut
review
board
univers
alabama
birmingham
uab
committe
human
research
public
ethic
school
medic
scienc
kwame
nkrumah
univers
scienc
technolog
knust
kumasi
total
hivneg
hivposit
peopl
gave
inform
consent
particip
studi
particip
complet
survey
sociodemograph
factor
age
sex
educ
occup
household
live
condit
blood
sampl
ml
collect
particip
edta
vacutain
tube
train
clinic
personnel
blood
separ
plasma
peripher
blood
mononuclear
cell
pbmc
laboratori
kumasi
center
collabor
research
kccr
tropic
medicin
knust
centrifug
plasma
aspir
store
frozen
pbmc
prepar
use
ficollhypaqu
densiti
gradient
conduct
previous
jolli
cell
viabil
check
pbmc
store
frozen
liquid
nitrogen
ship
uab
determin
tcell
count
plasma
sampl
also
ship
uab
determin
afalb
level
liver
function
test
hiv
viral
load
hbv
surfac
antigen
hcv
antibodi
malaria
antigen
hivposit
hivneg
studi
particip
recruit
hospit
care
hivposit
neg
person
hivposit
studi
particip
previous
test
hiv
posit
test
result
avail
medic
chart
hivneg
particip
either
client
hospit
person
commun
without
hiv
diagnosi
plasma
sampl
test
hiv
use
coulter
antigen
assay
coulter
corpor
miami
fl
usa
confirm
neg
includ
hivneg
studi
afalb
level
plasma
determin
laboratori
dr
js
wang
use
ria
publish
previous
wang
et
al
briefli
plasma
sampl
concentr
highspe
centrifug
filtrat
use
microconcentr
mol
wt
filter
cutoff
resuspend
phosphatebuff
salin
pb
amount
plasma
albumin
determin
sampl
bromocresol
purpl
dye
bind
method
sigma
st
loui
mo
usa
amount
total
protein
determin
use
bradford
procedur
pierc
biotechnolog
inc
rockport
il
usa
total
protein
per
sampl
digest
pronas
calbiochem
la
jolla
ca
usa
bound
aflatoxin
extract
aceton
supernat
dri
vacuo
use
savant
speedvac
concentr
afalb
quantifi
ria
procedur
wang
et
al
normal
human
serumplasma
sampl
purchas
sigmaaldrich
authent
afbalbumin
standard
use
qc
purpos
accuraci
analysi
base
day
rang
lqc
pmol
afalb
hqc
pmol
afalb
withinday
imprecis
lqc
hqc
overal
variat
inaccuraci
imprecis
rate
within
averag
recoveri
pmol
afalb
valu
express
pmol
afalb
mg
albumin
limit
detect
assay
pmol
mg
albumin
hepat
function
test
conduct
plasma
particip
uab
hospit
laboratori
includ
test
liver
enzym
aspart
aminotransferas
ast
alanin
aminotransferas
alt
liver
transport
total
direct
indirect
bilirubin
liver
synthesi
albumin
total
protein
normal
rang
valu
base
report
univers
alabama
hospit
laboratori
bulletin
inform
revis
octob
absolut
count
calcul
product
total
lymphocyt
count
percentag
lymphocyt
tcell
determin
flow
cytometri
absolut
lymphocyt
count
deriv
white
blood
cell
wbc
count
leukocyt
differenti
count
perform
laboratori
depart
biochemistri
knust
circul
tcell
popul
determin
flow
cytometri
use
fluorescein
fitclabel
monoclon
antibodi
bd
pharmingen
san
diego
ca
usa
isotypematch
control
bd
pharmingen
use
experi
briefli
cell
wash
stain
monoclon
antibodi
min
dark
wash
twice
stain
buffer
pb
supplement
sodium
azid
fb
ph
bd
pharmingen
fix
paraformaldehyd
buffer
pb
bd
pharmingen
cell
subsequ
run
facscalibur
instrument
analys
use
cellquest
softwar
cell
gate
live
peripher
blood
lymphocyt
popul
identifi
forwardand
sidescatt
paramet
least
cell
acquir
rna
measur
use
quantit
revers
transcriptas
polymeras
chain
reaction
assay
amplicor
monitor
roch
diagnost
system
brandersburg
nj
usa
viru
ml
plasma
lyse
kit
lysi
buffer
hiv
rna
precipit
use
isopropanol
pellet
centrifug
wash
ethanol
rna
resuspend
kit
dilut
buffer
extract
rna
amplifi
detect
accord
manufactur
instruct
result
report
hiv
rna
copi
ml
undetect
valu
copi
assign
valu
antibodi
hbv
surfac
antigen
hbsag
plasma
sampl
determin
use
biorad
enzym
immunoassay
accord
manufactur
direct
biorad
redmont
wa
usa
briefli
specimen
control
ad
duplic
appropri
well
microwel
strip
plate
coat
mous
monoclon
antibodi
hbsag
antihb
incub
min
wash
peroxidaseconjug
mous
monoclon
antibodi
hbsag
ad
well
plate
incub
min
plate
wash
tetramethylbenzidin
tmb
substrat
solut
ad
well
incub
dark
min
room
temperatur
reaction
stop
addit
stop
solut
well
plate
read
spectrophotomet
nm
sampl
consid
initi
reactiv
antihb
absorb
greater
equal
cutoff
valu
cutoff
valu
determin
addit
mean
absorb
valu
neg
control
posit
sampl
determin
repeat
reactiv
duplic
test
qualit
detect
antibodi
hcv
plasma
conduct
use
abbott
hcv
enzym
immunoassi
accord
manufactur
direct
abbott
laboratori
abbott
park
il
usa
briefli
specimen
control
dispens
test
tube
dilut
use
diluent
mix
specimen
control
transfer
appropri
well
reaction
tray
one
polystyren
bead
coat
recombin
hcv
antigen
ad
specimen
control
incub
h
wash
horseradishconjug
goat
antihuman
antibodi
ad
well
incub
min
water
bath
bead
wash
transfer
assay
tube
incub
opd
substrat
solut
room
temperatur
min
reaction
stop
sulfur
acid
read
spectrophotomet
nm
test
sampl
optic
densiti
od
greater
equal
mean
absorb
three
neg
control
plu
time
mean
absorb
three
posit
control
consid
initi
reactiv
criteria
abbott
hcv
eia
posit
sampl
determin
repeat
reactiv
duplic
test
conduct
malaria
antigen
celisa
assay
cellab
pti
ltd
brookval
australia
detect
plasmodium
falciparium
antigen
plasma
studi
particip
assay
detect
p
falciparium
merozoit
antigen
circul
blood
day
postinfect
briefli
microwel
precoat
antip
falciparium
monoclon
captur
antibodi
plasma
sampl
ad
coat
well
p
falciparium
malaria
antigen
allow
bind
present
h
humid
chamber
room
temperatur
posit
neg
sampl
run
assay
plate
wash
remov
unbound
materi
horseradish
peroxidas
label
antimalaria
monoclon
indic
antibodi
conjug
ad
well
bind
captur
p
falciparium
malaria
antigen
plate
incub
h
humid
chamber
room
temperatur
wash
fresh
enzym
substrat
solut
chromogen
ad
test
well
incub
dark
min
room
temperatur
reaction
stop
use
stop
solut
plate
read
spectrophotomet
blank
machin
air
absorb
valu
neg
control
less
od
unit
assay
valid
cutoff
level
determin
ad
valu
neg
control
specimen
absorb
valu
cutoff
consid
posit
p
falciparium
antigen
assay
shown
detect
p
falciparium
infect
parasitaemia
low
sensit
specif
respect
data
survey
clinic
test
enter
microsoft
excel
import
sa
softwar
packag
version
statist
analyt
system
gari
nc
usa
statist
analysi
mean
standard
deviat
obtain
distribut
select
variabl
hiv
statu
tabl
student
ttest
perform
evalu
signific
differ
group
absolut
rel
frequenc
n
obtain
distribut
select
variabl
aflatoxin
level
hivposit
popul
median
pmol
mg
albumin
tabl
mean
standard
deviat
sd
hivposit
group
afalb
median
pmol
mg
albumin
respect
log
transform
afalb
data
prior
analysi
result
differ
result
thu
present
result
shown
logist
regress
use
determin
associ
clinic
result
afalb
tabl
categor
shown
tabl
base
revis
classif
system
centr
diseas
control
prevent
cdc
viral
load
categor
base
publish
research
show
peopl
viral
load
copi
ml
blood
show
diseas
progress
greater
period
compar
peopl
higher
viral
load
rinaldo
et
al
world
health
organ
design
viral
load
copi
ml
evid
virolog
failur
variabl
statist
signific
p
bivari
analysi
known
associ
aflatoxin
base
extant
literatur
incorpor
model
use
backward
stepwis
techniqu
hosmer
lemshow
crude
odd
ratio
confid
interv
ci
gener
measur
associ
variabl
aflatoxin
level
median
aflatoxin
level
multipl
linear
regress
analysi
also
employ
assess
relationship
aflatoxin
level
plasma
clinic
factor
tabl
tabl
show
differ
sociodemograph
characterist
hivposit
neg
group
two
group
differ
age
howev
hivposit
particip
significantli
p
higher
number
total
person
children
household
receiv
significantli
higher
monthli
incom
signific
differ
hivposit
neg
particip
term
hbv
infect
malaria
parasitaemia
hivposit
individu
like
level
aflatoxin
median
level
compar
hivneg
person
characterist
particip
shown
tabl
tabl
show
hivposit
particip
significantli
higher
total
protein
lower
serum
albumin
higher
indirect
bilirubin
higher
alt
ast
level
hivneg
particip
although
indirect
bilirubin
alt
within
normal
refer
rang
group
ast
normal
rang
group
especi
hivposit
group
elev
ast
exclus
liver
damag
might
reflect
damag
tissu
mean
afalb
level
hivposit
group
mean
pmol
mg
albumin
significantli
higher
hivneg
group
mean
pmol
mg
albumin
tabl
figur
afalb
level
total
group
rang
pmol
mg
albumin
mean
pmol
mg
pmol
mg
hivposit
group
afalb
rang
pmol
mg
albumin
pmol
mg
hivneg
group
pmol
mg
albumin
pmol
mg
hivposit
studi
particip
divid
low
high
afalb
group
base
group
median
afalb
level
pmol
mg
albumin
low
afalb
pmol
mg
high
afalb
pmol
mg
bivari
multivari
analys
differ
tcell
count
two
group
statist
signific
either
analysi
tabl
bivari
analysi
signific
associ
hiv
viral
load
afalb
level
particip
high
afalb
level
like
low
level
total
protein
though
statist
signific
also
nonsignific
increas
odd
low
albumin
high
ast
high
total
indirect
bilirubin
level
posit
hepat
b
malaria
infect
higher
afalb
level
howev
contrari
statist
signific
likelihood
high
direct
bilirubin
level
high
aflatoxin
level
multivari
analysi
associ
depend
variabl
maintain
direct
relationship
afalb
level
seen
bivari
analysi
statist
signific
find
increas
odd
higher
hiv
viral
load
higher
direct
bilirubin
level
higher
aflatoxin
level
depend
variabl
afalb
level
enter
linear
regress
model
continu
variabl
tabl
higher
level
afalb
associ
lower
level
albumin
hand
particip
higher
afalb
level
like
higher
total
direct
bilirubin
level
investig
associ
certain
clinic
paramet
afalb
level
among
hivposit
neg
individu
almost
hivposit
hivneg
popul
posit
afalb
blood
agreement
previou
report
afalb
level
ashanti
region
ghana
jolli
et
al
result
suggest
region
aflatoxin
exposur
hivposit
peopl
like
higher
level
afalb
blood
compar
hivneg
individu
observ
may
connect
impair
liver
function
demonstr
hivposit
individu
feczko
possibl
hivposit
individu
decreas
abil
detoxifi
aflatoxin
metabolit
studi
bovin
hepatocyt
show
afb
biotransform
result
hydroxyl
demethyl
metabolit
well
afb
epoxid
involv
cytochrom
enzym
system
kuilman
et
al
human
hepat
cell
thought
cytochrom
isoenzym
cypia
contribut
format
metabolit
kuilman
et
al
high
afalb
result
consist
outcom
liver
injuri
ie
increas
cyp
phase
metabol
decreas
gst
phase
ii
metabol
afalb
product
phase
metabol
mediat
cyp
believ
hivinduc
inflamm
liver
injuri
may
stimul
cyp
afb
metabol
activ
phase
metabol
decreas
gst
accumul
afbepoxid
increas
afalb
level
blood
hand
hivinduc
malnutrit
liver
injuri
decreas
overal
albumin
made
liver
concentr
serv
denomin
afalb
assay
even
similar
afb
dietari
exposur
reason
hiv
patient
higher
level
afalb
nonhiv
patient
howev
also
possibl
aflatoxin
respons
liver
diseas
sinc
aflatoxin
induc
injuri
hepat
parenchyma
biliari
tract
becker
antiretrovir
arv
could
also
play
major
role
liver
toxic
hivposit
patient
treatment
sulkowski
et
al
aceti
et
al
bonacini
et
al
result
aflatoxin
build
blood
thirti
per
cent
studi
particip
arv
surpris
find
hivposit
particip
significantli
higher
level
total
protein
higher
total
indirect
bilirubin
higher
alt
ast
level
lower
serum
albumin
level
hivneg
particip
tabl
sever
antiretrovir
shown
associ
elev
liver
enzym
bonacini
et
al
inde
serum
aminotransferas
alt
ast
identifi
use
marker
liver
cell
injuri
wu
et
al
lower
plasma
albumin
level
indic
synthesi
function
liver
compromis
hivposit
particip
bilirubin
specif
signal
hepat
injuri
elev
serum
bilirubin
found
hiv
patient
treat
haart
bonacini
previous
tao
et
al
report
close
associ
afalb
level
direct
bilirubin
level
nonhiv
infect
minor
close
associ
afalb
albumin
liver
function
test
hiv
infect
minor
less
year
close
associ
afalb
indirect
bilirubin
nonhivinfect
adult
author
report
increas
plasmaserum
bilirubin
result
aflatoxin
treatment
rat
rastogi
et
al
rabbit
raval
et
al
guerr
et
al
latter
studi
increas
conjug
direct
bilirubin
compar
higher
increas
unconjug
indirect
bilirubin
higher
total
bilirubin
level
indic
liver
cell
damag
bile
duct
damag
within
liver
elev
direct
conjug
bilirubin
indic
decreas
bilirubin
secret
liver
bile
duct
obstruct
like
aflatoxin
may
contribut
suboptim
liver
function
test
result
obtain
sinc
aflatoxin
also
shown
independ
associ
impair
liver
function
hepatocellular
carcinoma
coulter
et
al
cdc
strosnid
et
al
find
significantli
higher
level
direct
bilirubin
associ
high
afalb
logist
regress
significantli
higher
level
total
direct
bilirubin
linear
regress
indic
bilirubin
level
elev
high
aflatoxin
exposur
bilirubin
may
prove
use
indic
high
afalb
hivposit
peopl
aflatoxin
prone
area
also
linear
regress
result
show
associ
lower
level
albumin
high
afalb
level
indic
aflatoxin
also
compromis
synthesi
function
liver
hivposit
peopl
interest
find
significantli
higher
viral
load
level
almost
threefold
among
hivposit
particip
high
afalb
level
compar
low
afalb
level
multivari
analysi
afb
report
caus
signific
fivefold
increas
chloramphenicol
acetyltransferas
cat
report
gene
link
promot
sequenc
long
termin
repeat
ltr
yao
et
al
increas
rate
provir
transcript
determin
interact
cellular
transcript
factor
cognat
sequenc
ltr
mechan
afb
increas
transcript
report
tcdd
shown
increas
infecti
titr
experiment
system
pokrovski
et
al
tsyrlov
pokrovski
afb
potent
increas
cat
activ
tcdd
although
studi
crosssect
find
hivposit
particip
higher
afalb
level
also
higher
viral
load
signific
given
aflatoxin
previous
shown
associ
immun
suppress
numer
anim
studi
pier
pestka
bondi
gabal
azzam
marin
et
al
gambian
children
turner
et
al
hivneg
posit
ghanaian
jiang
et
al
jiang
et
al
perhap
aflatoxin
hiv
may
act
synergist
suppress
immun
consequ
lead
higher
viral
load
also
possibl
aflatoxin
effect
liver
suppress
immun
system
contribut
subtl
differ
present
hivaid
subsaharan
africa
region
develop
world
compar
develop
countri
aflatoxin
contamin
food
crop
rampant
given
signific
find
research
urgent
need
would
employ
rigor
studi
design
shed
light
possibl
role
aflatoxin
liver
diseas
viral
load
hivposit
peopl
find
increas
viral
load
associ
high
afalb
level
poignant
given
advent
haart
hiv
larg
chronic
diseas
aflatoxin
truli
act
synergi
hiv
haart
damag
liver
function
take
haart
would
part
measur
toward
holist
manag
hivaid
diseas
comprehens
approach
would
requir
multidisciplinari
strategi
toward
manag
hiv
patient
involv
way
reduc
exposur
aflatoxin
meal
would
impli
educ
affect
commun
adopt
better
preharvest
crop
storag
method
provid
enterosorb
novasil
drug
oltipraz
wang
et
al
demonstr
reduc
serum
afalb
implement
polici
chang
would
improv
agricultur
method
enforc
known
allow
limit
aflatoxin
food
meant
human
consumpt
studi
sever
potenti
limit
appar
crosssect
natur
prevent
establish
caus
effect
relationship
therefor
studi
invari
preliminari
report
associ
interpret
find
lead
way
use
vigor
studi
design
test
observ
associ
sinc
hivposit
individu
myriad
clinic
condit
similar
overlap
pathophysiolog
pathway
difficult
extric
observ
associ
result
hiv
infect
per
se
hiv
treatment
result
accompani
opportunist
infect
thirdli
sinc
measur
afalb
due
cogniz
must
taken
fact
mycotoxin
fumonisin
occur
food
kpodo
et
al
may
similar
action
practic
implic
find
relat
possibl
role
aflatoxin
may
play
progress
liver
diseas
hivaid
aflatoxin
may
impact
outcom
hiv
treatment
manag
area
exposur
toxin
especi
food
ubiquit
distribut
aflatoxin
b
albumin
adduct
afalb
level
pmolmg
albumin
among
hivposit
hivneg
total
studi
particip
afalb
level
total
studi
group
hivposit
group
rang
pmolmg
albumin
mean
sd
total
hivposit
group
pmol
mg
respect
hivneg
group
afb
level
rang
pmol
mg
albumin
mean
pmol
mg
tabl
sociodemograph
characterist
hivposit
neg
particip
age
